tachycardia semaglutide Frontiers Can Wegovy (semaglutide) cause palpitations?

The organization also is suing the FDA over compounding restrictions for semaglutide

At higher doses of 8 mg and 12 mg, they experienced an average decline of 17% of their initial weight after 36 weeks

These changes reflect a broader shift that began in late 2025 and continues into 2026

For many patients, taste changes are most noticeable during the initial weeks of treatment or following dose increases , often coinciding with the period when gastrointestinal adverse effects such as nausea are most prominent

This medication helps your pancreas release the right amount of insulin when your blood sugar is high, aiding in better glycemic control

GLP-1RA therapy was initially developed to treat type 2 diabetes